US Patent

US10265404 — Compositions, gels and foams with rheology modulators and uses thereof

Formulation · Assigned to Foamix Pharmaceuticals Ltd · Expires 2030-10-01 · 4y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compositions, including gels and foams, with rheology modulators for cosmetic or pharmaceutical use.

USPTO Abstract

The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: US10265404
Jurisdiction: US
Classification: Formulation
Expires: 2030-10-01
Drug substance claim: No
Drug product claim: Yes
Assignee: Foamix Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.